- Original research article
- Open Access
Placement of self-expandable bifurcated metallic stents without use of fluoroscopic and guidewire guidance to palliate central airway lesions
© Özdemir et al. 2016
Received: 6 January 2016
Accepted: 19 February 2016
Published: 30 April 2016
Self-expandable metallic stents (SEMS) can be used to treat malignant obstructions and fistulas of the central airways. SEMS can be placed using different methods. Recently, a rigid bronchoscope has been used for stent placement without the need for fluoroscopy. We retrospectively evaluated patients for whom SEMS were placed using a rigid bronchoscope, without employing guidewires or fluoroscopy. We describe the intra- and post-procedural complications of the method.
Data collected between January 2014 and July 2015 were retrospectively evaluated by reference to hospital records.
The mean patient age was 58.14 ± 8.48 years (44–72 years) and 13 out of the 14 patients were male. Twelve had lung cancer, one a thyroid papillary carcinoma with a bronchomediastinal fistula, and one an esophageal carcinoma with a tracheoesophageal fistula. Covered metallic Y-shaped stents were placed in all patients. Before placement, argon plasma coagulation was performed on two patients, diode laser treatment on four, and de-obstruction on nine. No procedure-related mortality was noted. Only two patients required follow-up in the intensive care unit; they were moved to a regular ward after two days. No patient required stent replacement or repositioning. The most common early complication was mucus plugs.
Endobronchial placement of covered self-expandable metallic stents was safe and readily performed in patients with airway obstructions. Neither fluoroscopic nor guidewire guidance was required. Neither patients nor staff were exposed to radiation, and costly guidewire guidance was not necessary. The procedure is cost-effective.
Beside surgical methods, stent applications by endoscopic methods are also used as a part of multidisplinary approach in the treatment of benign or malign central airway lesions [1–3]. Dumon was the first to place silicon stents in the airways. Today, various types of silicon and metallic stents can be used to treat both benign and malignant airway diseases .
Although the use of a rigid bronchoscopic approach is essential when placing silicon stents, self-expandable metallic stents (SEMS) can be placed by various methods. The best-known method is flexible bronchoscopy (FB). SEMS can also be placed under fluoroscopic or guidewire guidance in patients under conscious sedation [5, 6]. Various other methods have been described in the literature. The method of choice is influenced by the general clinical condition of the patient, the capacity of the treating unit, and the experience of the team. Guidelines for the use of either guidewires alone or guidewires in combination with fluoroscopy have been published [7, 8]. In one study a technique employing rigid bronchoscopy, without the need for either fluoroscopy or guidewires, has been developed .
Metallic stent placement via FB, under fluoroscopic or guidewire guidance, using only local anesthesia, is popular when treating patients for whom surgery and rigid bronchoscopy are contra-indicated. However, under FB guideness fluoroscopic and guidewire guidance is costly, requires specialized technical equipment and experienced staff, and poses a radiation risk . Not all interventional pulmonology units have all the requisite equipment. Electrocautery, argon plasma coagulation (APC), laser treatments, and cryotherapy, are usually needed by patients for whom interventional pulmonology approaches are planned to treat central airway disease. SEMS placement via bronchoscopy under general anesthesia affords many advantages. Bronchoscopy under general anesthesia prevents coughing or patient movement, which render an endoscopic approach difficult. Blood clots and secretions in the airways can be quickly removed. Patency of the stenotic airway segment can be maintained by mechanical dilatation and desobstruction and bleeding control is afforded by pressure exerted by the bronchoscope [10–13].
In this manuscript we review the efficacy and safety of SEMS placement using a rigid bronchoscope, without fluoroscopic or guidewire guidance, in 14 patients with central airway diseases treated in our interventional pulmonology unit.
We studied 14 patients with central airway disease in whom SEMS were placed from January 2014 to June 2015. Data were retrospectively collected from patient records. Our local institutional ethics committee approved the work (Yedikule Chest Disease and Thoracic Surgery Training and Research Hospital Ethical Committee; version no:3983-2015/46). All patients were evaluated by both a pulmonologist and a thoracic surgeon before their procedures, and appropriate endoscopic approaches were defined. Clinical status, symptoms, primary diagnosis, prior treatment, and survival were evaluated. SEMS were placed with or without electrocautery and APC or other laser treatment, as appropriate. All procedures were performed using a rigid bronchoscope (Efer Dumon, EFER Endoscopy, La Ciotat, France) under general anaesthesia. Propofol, alfentanil, and rocuronium (a muscle relaxant) were given intravenously. Stent diameter and localization were determined using both rigid and FB (Karl Storz 11001BN1, Berlin, Germany). We placed two different types of commercial SEMS (Micro-Tech, Nanjing, China; Aerstent, Leufen, Germany).
Intraluminal treatments other than SEMS placement
We used rigid tracheal and bronchial tubes 10–12 mm in outer diameter. To treat intraluminal and mixed-type stenosis evident after devascularization of the endobronchial component of the tumor using a diode laser or APC, a rigid bronchoscope was initially employed to remove mechanical obstructions. If a hemorrhage at the base of the lesion required treatment, APC was used to achieve coagulation. Each extraluminal stenosis was dilated using an esophageal balloon (delivered via an endoscopic balloon dilation catheter; Balton, Warsaw, Poland), or a rigid bronchoscope, prior to stent insertion. A diode laser operating at 980 nm (4–25 W, pulsed mode; Biolitec Ceralas D 25, Jena, Germany) was used for endobronchial treatment. APC (40 W, blended mode/continuous flow) was delivered using a device manufactured by ERBE Elektromedizin Gmbh (Tübingen, Germany). The power levels were those recommended by the manufacturer.
Hemorrhages developing during the procedure were defined as minimal (no additional intervention needed); moderate (controllable by APC and diode laser coagulation); and severe (>100 mL). All hypoxemia (desaturation below 90 % for more than 1 min), any respiratory insufficiency requiring mechanical ventilation, arrhythmia, hypotension, and death within 24 h after the procedure, were considered to be complications. Follow-up FB was performed 24 h after SEMS placement. Airway damage, stent opening, stent migration, and retention of secretions were evaluated.
The mean patient age (14 patients) was 58.14 ± 8.48 years (44–72 years); two patients were female. SEMS were placed in 12 (85.72 %) patients to treat airway obstructions caused by lung cancer (11 NSCLCs, 1 SCLC); in one (7.14 %) to treat a bronchomediastinal fistula caused by papillary thyroid carcinoma; and in one (7.14 %) to treat a tracheoesophageal fistula caused by esophageal carcinoma. The mean ASA (American Society of Anesthesiologists) patient score prior to intervention was 2.64 ± 0.74 (range 1–4).
Dermographical characteristics and interventions
Patients’ number, n
58.14 ± 8.48
Sex (f/m), n
Airway obstruction due to lung cancer
Bronchomediastinal fistula due to thyroid papillary carcinoma
Tracheosophageal fistula due to eosophageal carcinoma
2.64 ± 0.74
Argon plasma coagulation
Balon dilatation or mechanical desobstruction
The mean procedure time was 49.64 ± 13.56 (30–80) min. Two patients developed minimal and four moderate hemorrhage. No severe hemorrhage was observed. No procedure-related mortality occurred. Only two patients were sent to the intensive care unit postoperatively, because of respiratory insufficiency. They underwent non-invasive mechanical ventilation and were moved to a regular ward after 48 h. Airway status and stent function were evaluated in all patients 24 h after their procedures. No stent replacement or repositioning was required. Three patients exhibited retention of secretions in the absence of severe stent obstruction. The secretions were cleared via FB.
We used rigid bronchoscopy and FB to place bifurcated SEMS. The procedure was efficient and safe. Neither fluoroscopy nor guidewires were needed to treat central airway obstructions caused principally by cancerous lesions. No severe complications were observed and all stents were successfully placed. Today, both silastic and metallic stents can be used to treat central airway lesions. Bifurcated stents are preferred when airway stenosis involves the carinal area, or when a tracheoesophageal fistula is present or a fistula might develop at the anastomotic site after operation. Rigid bronchoscopy must be used for stent placement in such situations [14–16]. In addition, team experience is important, and various maneuvers are required to prevent laceration of the airways, main vessels, and tracheobronchial wall when placing silicon stents .
Modern SEMS are mostly silicon-covered, made of nickel titanium alloy, and feature shape memory. SEMS placement can be achieved by rigid bronchoscopy under general anaesthesia or employing fluoroscopic or guidewire guidance under local anaesthesia. Most commonly, FB is used under local anaesthesia with fluoroscopic guidance [6, 7]. Herth et al. placed plain metallic stents in 96 patients using FOB with guidewire guidance; fluoroscopy was not employed. No procedure-related complication was noted . Lin et al. used FB with guidewire guidance to treat airway lesions; fluoroscopy was not employed. Plain metallic stents were placed in 26 patients who then underwent endotracheal tube intubation because of acute respiratory insufficiency. Later, 14 patients were weaned from mechanical ventilation . The cited study did not describe procedure-related complications in detail; but one case of pneumothorax and one of stent migration were reported.
SEMS placement without the use of either fluoroscopic or guidewire guidance has been reported in one study . Husain et al. placed ultraflex airway stents in 66 patients with malignant and benign airway obstructions. Four complications were reported < 12 h postoperatively; none of which were stent-related. These early complications were hypoxia, lobular collapse, hemorrhage, and respiratory insufficiency. Differently, in our study, bifurcated stents were placed in all patients. We observed minimal or moderate hemorrhage in six patients; all hemorrhages were controlled. We encountered no complication-related deaths, but two patients required non-invasive mechanical ventilation for two days after their procedures. All bifurcated stents were successfully placed and no stent-related complication was observed.
Various endoscopic methods can be used, alone or in combination, to treat central airway lesions, depending on the underlying disease, the type of stenosis, and the clinical condition of the patient [19, 20]. In patients for whom endoscopy is planned using a multidisciplinary approach, and who can tolerate general anaesthesia, rigid rather than FB affords advantages . The borders of the stenotic segment can be directly evaluated and dilatation, hot intervention, and mechanical de-obstruction, can be performed. Hemorrhage and ventilatory deficiency can be effectively managed, and secretions aspirated. We prefer to add various interventions, via rigid bronchoscopy, during SEMS placement in our interventional pulmonology unit. We combined such interventions with SEMS placement in ten patients (71.4 %).
Although complications may be of concern, and although general anaesthesia is costly, safety considerations suggest that rigid bronchoscopy is the best option for endoscopic interventions, and this is the practice in our unit.
General anaesthesia increases procedure time and is associated with anaesthesia-related complications. Our mean procedure time was 49.64 ± 13.56 (30–80) min. When FB was used to place SEMS (ultraflex stent) in sedated patients, the mean procedure time was 24.2 ± 8.8 min . The longer time of our study is explained by the fact that we combined stent placement with other procedures. Using FOB, a stent is placed without prior de-obstruction; rigid bronchoscopy allows obstructions to be removed. The fact that we did not observe any procedure-related complication associated with procedure duration supports the notion that our method is safe.
We studied short-term, but not long-term, effectiveness and safety. Upon FB performed 24 h postoperatively, three patients exhibited secretion retention that did not severely obstruct the stents; therefore the secretions were removed. No stent malpositioning or migration was observed.
The limitations of our study is that we did not evaluate the long term results of the stent application but only the application method. Another limitation is that our study population is small.
In conclusion, endobronchial placement of covered self-expandable bifurcated metallic stents via rigid bronchoscopy appears to be safe and simple in patients with airway obstructions and neither fluoroscopic nor guidewire guidance is crucial. Also by rigid bronchosopy, treatment modalities other then stent placement can be applied. This approach eliminates exposure of patients and staff to radiation.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Bolliger CT, Mathur PN, Beamis JF, Becker HD, Cavaliere S, Colt H, et al. European Respiratory Society/American Thoracic Society. ERS/ATS statement on interventional pulmonology. European Respiratory Society/American Thoracic Society. Eur Respir J. 2002;19(2):356–73.View ArticlePubMedGoogle Scholar
- Seijo LM, Sterman DH. Interventional pulmonology. N Engl J Med. 2001;344(10):740–9.View ArticlePubMedGoogle Scholar
- Casal RF. Update in airway stents. Curr Opin Pulm Med. 2010;16(4):321–8.View ArticlePubMedGoogle Scholar
- Dumon JF. A dedicated tracheobronchial stent. Chest. 1990;97(2):328–32.View ArticlePubMedGoogle Scholar
- Hautmann H, Bauer PKJ, Huber RM. Flexible bronchoscopy: a safe method for metal stent implantation in bronchial disease. Ann Thorac Surg. 2000;69:398–401.View ArticlePubMedGoogle Scholar
- Saad CP, Murthy S, Krizmanich G, Mehta AC. Self-expandable metallic airway stents and flexible bronchoscopy: long-term outcomes analysis. Chest. 2003;124(5):1993–9.View ArticlePubMedGoogle Scholar
- Dasgupta A, Dolmatch BL, Abi-Saleh WJ, Mathur PN, Mehta AC. Self-expandable metallic airway stent insertion employing flexible bronchoscopy: preliminary results. Chest. 1998;114(1):106–9.View ArticlePubMedGoogle Scholar
- Herth F, Becker HD, LoCicero 3rd J, Thurer R, Ernst A. Successful bronchoscopic placement of tracheobronchial stents without fluoroscopy. Chest. 2001;119(6):1910–2.View ArticlePubMedGoogle Scholar
- Husain SA, Finch D, Ahmed M, Morgan A, Hetzel MR. Long-term follow-up of ultraflex metallic stents in benign and malignant central airway obstruction. Ann Thorac Surg. 2007;83(4):1251–6.View ArticlePubMedGoogle Scholar
- Bacon JL, Patterson CM, Madden BP. Indications and interventional options for non-resectable tracheal stenosis. J Thorac Dis. 2014;6(3):258–70. PubMedPubMed CentralGoogle Scholar
- Crerar-Gilbert A, Madden BP. The use of rigid bronchoscopy for bronchial stenting in patients with tracheal stenosis. J Cardiothorac Vasc Anesth. 2007;21:320.View ArticlePubMedGoogle Scholar
- Jones C, Crerar-Gilbert AJ, Madden BP. Anaesthesia for endobronchial intervention and tracheobronchial stents. Curr Anaesth Crit Care. 2009;20:160–3.View ArticleGoogle Scholar
- Guibert N, Mazieres J, Marquette CH, Rouviere D, Didier A, Hermant C. Integration of interventional bronchoscopy in the management of lung cancer. Eur Respir Rev. 2015;24:378–91.View ArticlePubMedGoogle Scholar
- Saji H, Furukawa K, Tsutsui H, Tsuboi M, Ichinose S, Usuda J, et al. Outcomes of airway stenting for advanced lung cancer with central airway obstruction. Interact Cardiovasc Thorac Surg. 2010;11(4):425–8.View ArticlePubMedGoogle Scholar
- Ernst A, Majid A, Feller-Kopman D, Guerrero J, Boiselle P, Loring SH, et al. Airway stabilization with silicone stents for treating adult tracheobronchomalacia: a prospective observational study. Chest. 2007;132(2):609–16.View ArticlePubMedGoogle Scholar
- Yata S, Kaminou T, Hashimoto M, Ohuchi Y, Sugiura K, Adachi A, et al. Successful closure of intractable tracheoesophageal fistula using a combination of a modified silicon stent and metallic stents. Acta Radiol Short Rep. 2012;19:1(2).Google Scholar
- Conacher ID. Anaesthesia and tracheobronchial stenting for central airway obstruction in adults. Br J Anaesth. 2003;90(3):367–74.View ArticlePubMedGoogle Scholar
- Lin SM, Lin TY, Chou CL, Chen HC, Liu CY, Wang CH, et al. Metallic stent and flexible bronchoscopy without fluoroscopy for acute respiratory failure. Eur Respir J. 2008;31(5):1019–23.View ArticlePubMedGoogle Scholar
- Hsia D, Musani AI. Interventional pulmonology. Med Clin North Am. 2011;95(6):1095–114.View ArticlePubMedGoogle Scholar
- Akulian J, Feller-Kopman D, Lee H, Yarmus L. Advances in interventional pulmonology. Expert Rev Respir Med. 2014;8(2):191–208.View ArticlePubMedGoogle Scholar
- Alraiyes AH, Machuzak MS. Rigid bronchoscopy. Semin Respir Crit Care Med. 2014;35(6):671–80.View ArticlePubMedGoogle Scholar